跳至主要内容
临床试验/NCT04007653
NCT04007653Unknown不适用

Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2017年4月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,200
试验地点
1
主要终点
Post thrombotic syndrome (PTS)

研究概览

简要总结

The HOKUSAI post VTE study contains of two different research questions; one on the long term outcomes of deep vein thrombosis and one on the long term effects of pulmonary embolism, post thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (CTEPH) respectively. Our aim of the study is to compare the long term outcomes along with the quality of life assessment of VTE in a group treated with heparin+VKA versus a group treated with heparin+edoxaban in the acute setting.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Participant in the HOKUSAI VTE trial

排除标准

  • 未提供

结局指标

主要结局

Post thrombotic syndrome (PTS)

时间窗: up to 10 years

PTS according to Villalta

次要结局

  • Chronic thromboembolic pulmonary hypertension (CTEPH)(up to 10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

S. Middeldorp

Principal Investigator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

研究点 (1)

Loading locations...

相似试验